CompletedInterventionalNot ApplicableUpdated Jan 31, 2013
Treatment With Duloxetine for OCD Patients | NCT00399022 | Trialant
WithdrawnInterventionalNot ApplicableUpdated Jan 31, 2008
Treatment With Duloxetine for OCD Patients
ClinicalTrials.gov ID
NCT00399022
Lead Sponsor
Sheba Medical CenterOTHER_GOV
Overall Status
Withdrawn
Study Type
Interventional
Phase
Not Applicable
Enrollment
40Estimated
Last Update Posted
Jan 31, 2008Estimated
Brief Summary
Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI
OCD
Duloxetine
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
OCD as main diagnosis according to DSM-IV
Age 18 to 65
Men and women
YBOCS score is 18 or more, or 12 or more in case of only obsessions
Exclusion Criteria:
Patients treated with Duloxetine, currently or in the past
Patients having comorbid schizophrenia or psychotic disorder or bipolar disorder Patients with substance abuse disorder in the last 6 months Patients who were suicidal or did serious suicide attempt in the last year Pregnant or lactating women, or woman of childbearing potential, which is not using adequate contraception Patients with neurologic disturbance or disorder Patients with serious or imbalanced medical condition Patients with allergic response to SSRI or duloxetine Patients who started new treatment (CBT or pharmacology) in less than 3 months